Peer-influenced content. Sources you trust. No registration required. This is HCN.

American Journal of Health-System Pharmacy (AJHP)ASHP Statement on Artificial Intelligence in Pharmacy

The American Society of Health-System Pharmacists has released an expanded statement addressing AI’s role in pharmacy practice, emphasizing pharmacist leadership in AI implementation, validation, and governance while establishing ethical guidelines for safe deployment across all practice settings.


⚖️ Professional Impact Points

  • Clinical Leadership Role: Pharmacists must lead AI decision-making, design, and validation processes rather than serving as passive users of technology developed by others.
  • Validation Responsibility: Only 37% of health systems report readiness to validate AI tools despite 73% expecting validation requirements, creating professional liability gaps.
  • Scope Evolution: AI automation will shift pharmacist focus toward high-value patient care while enabling technicians to assume historically pharmacist-performed operational tasks.
  • Educational Competency: Professional competency now requires understanding AI model strengths, weaknesses, and failure modes to maintain standard of care and avoid liability.
  • Governance Participation: Pharmacists must embed themselves in organizational, regional, and national AI policymaking to ensure medication-use process expertise guides regulatory development.

🏥 Practice Management Considerations

  • Documentation Strategy: Establish AI governance committees and policies addressing NIST framework compliance, with clear protocols for model validation, ongoing surveillance, and failure mode analysis to protect against liability when AI recommendations conflict with standard care.
  • Patient Communication Protocols: Develop staff training for addressing patient concerns about AI-generated health information, particularly as pharmacists become primary points of contact for AI-related patient education questions.
  • Legal Risk Assessment: Implement contingency plans for AI system downtimes, breaches, or recalls while ensuring staff competency in both clinical applications and AI model limitations to mitigate liability scenarios.
  • Staff Training Requirements: Mandate foundational AI education across all pharmacy personnel, including data science concepts, ethical considerations, prompt engineering for generative AI, and validation methodologies for clinical decision support systems.

HCN Medical Memo
Pharmacy leaders should proactively establish AI governance frameworks and staff competency programs rather than waiting for regulatory mandates. Organizations must balance AI adoption benefits with risk mitigation through comprehensive validation processes and staff education. Early engagement in AI policy development positions pharmacy departments as essential stakeholders in healthcare AI governance rather than passive technology recipients.


More on AI

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form